|
Volumn 41, Issue 10, 2011, Pages 1203-1208
|
Oncology market research provides a feasible index for standardization of colorectal cancer chemotherapy
|
Author keywords
Chemotherapy; Colorectal cance; Oncology market; Standardization
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CETUXIMAB;
DOXIFLURIDINE;
FLUOROURACIL;
FOLINIC ACID;
KRESTIN;
OXALIPLATIN;
PANITUMUMAB;
UFT;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL PRACTICE;
COLORECTAL CANCER;
HUMAN;
MAJOR CLINICAL STUDY;
ONCOLOGY;
ONCOLOGY MARKET RESEARCH;
PRACTICE GUIDELINE;
RESEARCH;
STANDARDIZATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
COLORECTAL NEOPLASMS;
GUIDELINE ADHERENCE;
HUMANS;
JAPAN;
MARKETING;
PRACTICE GUIDELINES AS TOPIC;
REFERENCE STANDARDS;
TIME AND MOTION STUDIES;
|
EID: 80053464529
PISSN: 03682811
EISSN: 14653621
Source Type: Journal
DOI: 10.1093/jjco/hyr123 Document Type: Article |
Times cited : (3)
|
References (9)
|